WESTBY KEITH (SVP & COO) sold 46.3% of their position (40K shares) of IVERIC BIO, INC. on the open market
Open‑market sale worth $937.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/3/2023ACC: 0001410939-23-000014
-40K
Net shares
Net seller
$937.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20K
Price / share
$23.03
Trade value
$460.60K
% of position
23.2%
2/1/2023
86.35K→66.35K
Common Stock
Direct
Shares
−20K
Price / share
$23.82
Trade value
$476.40K
% of position
30.1%
2/2/2023
66.35K→46.35K
Total
Net shares
−40K
Net value
-$937K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2023 | S · Sale | −20K | $23.03 | $460.60K | 23.2% | 86.35K | 66.35K |
| Common Stock Direct | 2/2/2023 | S · Sale | −20K | $23.82 | $476.40K | 30.1% | 66.35K | 46.35K |
| Total | −40K | -$937K | ||||||
Derivative Transactions0
No derivative transactions reported